Vancomycin-resistant Staphylococcus aureus: no apocalypse now
- 1 August 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (8) , 761-765
- https://doi.org/10.1046/j.1469-0691.2003.00734.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2001
- In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 2000
- Glycopeptide-intermediate Staphylococcus aureus: rediscovery of an old problem?Clinical Microbiology & Infection, 2000
- Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitalsJournal of Antimicrobial Chemotherapy, 2000
- Combinations of Vancomycin and β-Lactams Are Synergistic against Staphylococci with Reduced Susceptibilities to VancomycinAntimicrobial Agents and Chemotherapy, 1999
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal BacteremiaEmerging Infectious Diseases, 1999
- Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?Journal of Antimicrobial Chemotherapy, 1998
- Vancomycin-resistant Staphylococcus aureus: apocalypse now?The Lancet, 1997
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997